• Practice Areas
  • Sectors
  • Lawyers
  • Notaries



GSK Stockmann advises Target Global on a €50-million in-vestment in the Berlin start-up McMakler

GSK Stockmann advised VC investor Target Global on the latest financing round of the Berlin start-up McMakler. With a total volume of 50 million euros, this is one of the the largest financing rounds to date on the proptech market.

McMakler is a growing German start-up with operational headquarters in Berlin. Hanno Heintzenberg and Lukas Pieczonka founded McMakler in 2015, and now employ approximately 450 people working at over 100 locations throughout Germa-ny. As a proptech company, McMakler runs an online brokerage platform, using its own permanently employed brokers. The start-up is planning to expand in Germany, Austria and France in order to become a leading European online broker.

McMakler raised the capital for this development in a Series C financing totalling 50 million euros. The lead investors include Target Global and Israel Growth Partners (IGP).

The GSK Stockmann Berlin team led by Partner Dr Katy Ritzmann advised Target Global on all legal questions regarding the investment. Dr Ritzmann’s specialization in the Israeli legal market was very helpful since this made cooperation with IGP, the other lead investor, much easier. GSK Stockmann also was able to contribute its particular competence and experience in the VC financing of tech start-ups.